Impaired Regeneration in Dystrophic Muscle—New Target for Therapy von Yanay, Nurit, Rabie, Malcolm, Nevo, Yoram

Volltext

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2J/dy2J Mouse von Elbaz, Moran, Yanay, Nurit, Aga-Mizrachi, Shlomit, Brunschwig, Zivia, Kassis, Ibaa, Ettinger, Keren, Barak, Vivian, Nevo, Yoram

Volltext

Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function von Haziza, Sitvanit, Magnani, Roberta, Lan, Dima, Keinan, Omer, Saada, Ann, Hershkovitz, Eli, Yanay, Nurit, Cohen, Yoram, Nevo, Yoram, Houtz, Robert L, Sheffield, Val C, Golan, Hava, Parvari, Ruti

Volltext

Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and α9β1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell model von Ettinger, Keren, Lecht, Shimon, Arien-Zakay, Hadar, Cohen, Gadi, Aga-Mizrachi, Shlomit, Yanay, Nurit, Saragovi, H. Uri, Nedev, Hinyu, Marcinkiewicz, Cezary, Nevo, Yoram, Lazarovici, Philip

Volltext

The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy von Nevo, Yoram, Aga-Mizrachi, Shlomit, Elmakayes, Edva, Yanay, Nurit, Ettinger, Keren, Elbaz, Moran, Brunschwig, Zivia, Dadush, Oshrat, Elad-Sfadia, Galit, Haklai, Roni, Kloog, Yoel, Chapman, Joab, Reif, Shimon

Volltext

The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy von Nevo, Yoram, Aga-Mizrachi, Shlomit, Elmakayes, Edva, Yanay, Nurit, Ettinger, Keren, Elbaz, Moran, Brunschwig, Zivia, Dadush, Oshrat, Elad-Sfadia, Galit, Haklai, Roni, Kloog, Yoel, Chapman, Joab, Reif, Shimon

Volltext

Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy/dy mouse model by glatiramer acetate von Rabie, Malcolm, Yanay, Nurit, Fellig, Yakov, Konikov-Rozenman, Jenya, Nevo, Yoram

Volltext

Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy von Turjeman, Keren, Yanay, Nurit, Elbaz, Moran, Bavli, Yaelle, Gross, Moria, Rabie, Malcolm, Barenholz, Yechezkel, Nevo, Yoram

Volltext

Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy2J/dy2J mouse model by glatiramer acetate von Rabie, Malcolm, Yanay, Nurit, Fellig, Yakov, Konikov-Rozenman, Jenya, Nevo, Yoram

Volltext

Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse von Elbaz, Moran, Yanay, Nurit, Aga-Mizrachi, Shlomit, Brunschwig, Zivia, Kassis, Ibaa, Ettinger, Keren, Barak, Vivian, Nevo, Yoram

Volltext

Pax7, Pax3 and Mamstr genes are involved in skeletal muscle impaired regeneration of dy2J/dy2J mouse model of Lama2-CMD von Yanay, Nurit, Elbaz, Moran, Konikov-Rozenman, Jenya, Elgavish, Sharona, Nevo, Yuval, Fellig, Yakov, Rabie, Malcolm, Mitrani-Rosenbaum, Stella, Nevo, Yoram

Volltext

Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy 2J /dy 2J mouse model by glatiramer acetate von Rabie, Malcolm, Yanay, Nurit, Fellig, Yakov, Konikov-Rozenman, Jenya, Nevo, Yoram

Volltext

Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function: e1005388 von Haziza, Sitvanit, Magnani, Roberta, Lan, Dima, Keinan, Omer, Saada, Ann, Hershkovitz, Eli, Yanay, Nurit, Cohen, Yoram, Nevo, Yoram, Houtz, Robert L, Sheffield, Val C, Golan, Hava, Parvari, Ruti

Volltext

Variable Phenotypes of Knockin Mice Carrying the M712T Gne Mutation von Sela, Ilan, Yakovlev, Lena, Becker Cohen, Michal, Elbaz, Moran, Yanay, Nurit, Ben Shlomo, Uri, Yotvat, Hagit, Fellig, Yakov, Argov, Zohar, Mitrani-Rosenbaum, Stella

Volltext

Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery von Mitrani-Rosenbaum, Stella, Yakovlev, Lena, Becker Cohen, Michal, Telem, Michal, Elbaz, Moran, Yanay, Nurit, Yotvat, Hagit, Ben Shlomo, Uri, Harazi, Avi, Fellig, Yakov, Argov, Zohar, Sela, Ilan

Volltext

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy 2J /dy 2J Mouse von Elbaz, Moran, Yanay, Nurit, Aga‐Mizrachi, Shlomit, Brunschwig, Zivia, Kassis, Ibaa, Ettinger, Keren, Barak, Vivian, Nevo, Yoram

Volltext

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy super(2J)/dy super(2J) Mouse von Elbaz, Moran, Yanay, Nurit, Aga-Mizrachi, Shlomit, Brunschwig, Zivia, Kassis, Ibaa, Ettinger, Keren, Barak, Vivian, Nevo, Yoram

Volltext

Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and [alpha]9[beta]1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell... von Ettinger, Keren, Lecht, Shimon, Arien-Zakay, Hadar, Cohen, Gadi, Aga-Mizrachi, Shlomit, Yanay, Nurit, Saragovi, HUri, Nedev, Hinyu, Marcinkiewicz, Cezary, Nevo, Yoram, Lazarovici, Philip

Volltext

Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate von Dadush, Oshrat, Aga-Mizrachi, Shlomit, Ettinger, Keren, Tabakman, Rinat, Elbaz, Moran, Fellig, Yakov, Yanay, Nurit, Nevo, Yoram

Volltext

The Ras Antagonist, Farnesylthiosalicylic Acid , Decreases Fibrosis and Improves Muscle Strength in dy.sup.2J/dy.sup.2J Mouse Model of Muscular Dystrophy von Nevo, Yoram, Aga-Mizrachi, Shlomit, Elmakayes, Edva, Yanay, Nurit, Ettinger, Keren, Elbaz, Moran, Brunschwig, Zivia, Dadush, Oshrat, Elad-Sfadia, Galit, Haklai, Roni, Kloog, Yoel, Chapman, Joab, Reif, Shimon

Volltext